Altogether, our study shows that fascin can
promote tumor progression in vivo, but also unravels an unexpected role of fascin in tumor initiation.
Soluble Antibodies
Promote Tumor Progression by Inducing Immune Suppressive Cells Genetic Engineering & Biotechnology News April 13, 2018
During tumor development, rapid expansion of cancer cells creates a hypoxic microenvironment that is followed by periods of reoxygenation to
promote tumor progression.
Trp53 inactivation in the tumor microenvironment
promotes tumor progression by expanding the immunosuppressive lymphoid - like stromal network.
We suggest that stromal catabolism, via autophagy and mitophagy, fuels the anabolic growth of tumor cells,
promoting tumor progression and metastasis.
Not exact matches
Here, we will explore how the
tumor microenvironment
promotes oncogenic
progression, while protecting the
tumor from therapeutic intervention.
Of particular interest are how
tumor - specific metabolic changes
promote oncogenic
progression and how these changes can be exploited to develop more effective treatment options.
NK cells require active STAT5 to kill
tumor cells; however, when STAT5 is absent or inhibited, NK cells do the opposite: they accelerate cancer
progression by
promoting angiogenesis.
In the Dec. 1 issue of Science, the team from the MGH Center for Systems Biology describes a «crosstalk» between lung
tumors and bone marrow, which leads to the generation of a type of immune cell that travels to the
tumor and
promotes its
progression.
The researchers expanded the relevance of these findings to lung carcinoma, showing that soluble antibodies are generally important in the
tumor microenvironment to induce accumulation of MDSCs and
promote cancer
progression.
Nefedova studies molecular mechanisms by which bone marrow microenvironment
promotes tumor survival and
progression.
The pancreas seems to require two oncogenic events to initiate and
promote tumorigenesis with
tumor suppressors acting later to increase
progression to malignant disease.
Mitophagy defects arising from BNip3 loss
promote mammary
tumor progression to metastasis.
Anna Huttenlocher, University of Wisconsin, USA Neutrophils in the
Tumor Microenvironment Neutrophils, Wounds, and Cancer
Progression Stefan Kaufmann, Max Planck Institute, Germany Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells Kathryn Moore, New York University, USA MicroRNA -33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis Lalita Ramakrishnan, University of Cambridge, UK Myeloid Growth Factors
Promote Resistance to Mycobacterial Infection by Curtailing Granuloma Necrosis through Macrophage Replenishment Beth Stevens, Harvard University, USA Microglia: Dynamic Mediators of Synapse Development and Plasticity Do glia drive synaptic and cognitive impairment in disease?
Receptor Tyrosine Kinases and TLR / IL1Rs Unexpectedly Activate Myeloid Cell PI3K [gamma], A Single Convergent Point
Promoting Tumor Inflammation and
Progression.
ABL tyrosine kinases play an oncogenic role in human leukemias (4, 5) and
promote the
progression of solid
tumors (5, 6).
These findings provide evidence that IL - 15 may
promote tumor cell
progression via CD215 + myeloid cells, and IGF - 1 may be an important candidate that IL - 15 facilitates
tumor growth.
The mission of our lab is to improve therapy for patients with brain
tumors by elucidating the molecular mechanisms driving cancer initiation and
progression, and in doing so,
promote rigorous science and train the next generation of scientists.